Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology, Pulmonary |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 1/12/2019 |
| Start Date: | January 2016 |
| End Date: | August 1, 2019 |
Empowering Individuals Post-Cardiopulmonary Outpatient Rehabilitation to Continue to Live a Heart Healthy Lifestyle: Utilizing Mobile Health Technology
This is a randomized controlled trial of the feasibility and utility of implementing a
smartphone application (MVN) to maintain compliance with a Heart Healthy lifestyle after
discharge from a cardiac outpatient rehabilitation program. Patients will be randomized into
one of two groups: usual care (control: UC) or Movn mobile application (intervention: MVN).
This study will improve and strengthen data collection from this at-risk patient population
by recording baseline clinical and psycho social measures while gaining insight into
self-reporting of physical activity and frequency between the UC and MVN groups.
smartphone application (MVN) to maintain compliance with a Heart Healthy lifestyle after
discharge from a cardiac outpatient rehabilitation program. Patients will be randomized into
one of two groups: usual care (control: UC) or Movn mobile application (intervention: MVN).
This study will improve and strengthen data collection from this at-risk patient population
by recording baseline clinical and psycho social measures while gaining insight into
self-reporting of physical activity and frequency between the UC and MVN groups.
Inclusion Criteria:
- Current participants in The Joan and Joel Smilow Cardiac Rehabilitation and Prevention
Center (JJCRPC) of Rusk Rehabilitation Patient within two weeks of completing
outpatient cardiac rehabilitation
- Clinically stable: moderate to low risk strata by standardized clinical assessment
- Clinically stable: moderate to low risk strata by standardized clinical assessment
- no infections
- no unstable arrhythmias, aortic stenosis, thrombophlebitis, dissecting aneurysm or
symptomatic anemia
- controlled blood pressure-resting diastolic <100 mmHg, systolic <180mmHg
- no uncompensated heart failure NYHA Class 3-4
- stable angina (no chest pain for month)
- no 2nd or 3rd degree heart block
- no uncontrolled high grade exercise induced ventricular ectopy-hemodynamically stable
- Own an iPhone (version 3 or above), an iPad, or an iPod touch (version 4 or higher) or
Android phone or tablet
- Ability to use and comfortable with using mobile health technology to monitor physical
and psychosocial health
- Is comfortable using mobile applications
- English language fluency
- Ability to provide informed consent
Exclusion Criteria:
- Patients who do not fulfill all inclusion criteria stated above.
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Tamara Bushnik, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
